Publication & Citation Trends
Most Cited Works
Publications
93 total
Abstract CT158: Use of 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) as therapy for advanced non-small cell lung cancer (NSCLC) involving the CNS
Cited by 0
Semantic Scholar
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC PDF
Cited by 106
OpenAlex
Efficacy and Safety Results From a Phase II, Placebo‐Controlled Study of Onartuzumab Plus First‐Line Platinum‐Doublet Chemotherapy for Advanced Squamous Cell Non–Small‐Cell Lung Cancer
Cited by 31
Semantic Scholar
Efficacy and Safety of Onartuzumab in Combination With First‐Line Bevacizumab‐ or Pemetrexed‐Based Chemotherapy Regimens in Advanced Non‐Squamous Non–Small‐Cell Lung Cancer
Cited by 38
Semantic Scholar
Abstract CT052: Clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in cancers involving the CNS
Cited by 0
Semantic Scholar
Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4). OA
Cited by 42
Semantic Scholar
RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis.
Cited by 0
Semantic Scholar
RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis.
Cited by 0
Semantic Scholar
Research Topics
Viral Infections and Vectors
(22)
Viral Infections and Outbreaks Research
(21)
Lung Cancer Treatments and Mutations
(13)
Renal cell carcinoma treatment
(11)
Cancer Treatment and Pharmacology
(11)
Frequent Co-Authors
Affiliations
United States Army Medical Command
United States Department of the Army
Center for Biologics Evaluation and Research
Fitzsimons Army Medical Center
Frederick Community College